This course is developed by Medscape Education Global.
Medscape is one of the leading digital platforms for medical
education. A comprehensive array of innovative formats, in multiple
languages, insures the right educational solution is available to best
achieve desired objectives—from text-based articles to
state-of-the-art multimedia formats and the most sophisticated
simulation environments. Activity formats include Clinical Insights,
Expert Perspective, Instructional Series Programming, Next-Generation
Symposia, Patient-Case Approaches, including Simulation and Clinical Advances.
In this diabetes expert encounter, Drs Michael Nauck from Bochum,
Germany, and Xavier Cos from Barcelona, Spain, discuss the rationale
and the specifics of the latest guideline recommendations for the
appropriate use of long-acting and next-generation GLP-1 receptor
agonists in patients with type 2 diabetes. A particular focus is on
implementing their targeted usage in clinical practice and practical
aspects of intiating and titratingthese incretin-based therapies
safely and effectively in a primary care setting.
An overview of currently available GLP-1 RA injectable formulations
is included, and reference is made to the so far only available oral
formulation of a long-acting GLP-1 RA.
Made for: Diabetologists, Endocrinologists, Cardiologists,
Primary Care Physicians
Disease areas: Diabetes
Developed by: Medscape